Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bebo HealthXPAR:MLBBO 47 Equity-to-Asset is 0.59 as of Dec. 2025, which is 18% below its 10-year median of 0.72. GuruFocus rates XPAR:MLBBO with a GF Score™ of 47/100 and a GF Value™ of €0.03 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,132 Retail - Cyclical companies, Bebo Health ranks better than 70.94% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Bebo Health's Total Stockholders Equity for the quarter that ended in Dec. 2025 was €15.72 Mil. Bebo Health's Total Assets for the quarter that ended in Dec. 2025 was €26.64 Mil.
Therefore, Bebo Health's Equity to Asset Ratio for the quarter that ended in Dec. 2025 was 0.59.
The historical rank and industry rank for Bebo Health's Equity-to-Asset or its related term are showing as below:
XPAR:MLBBO'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.11 Med: 0.72 Max: 0.91
Current: 0.59
During the past 7 years, the highest Equity to Asset Ratio of Bebo Health was 0.91. The lowest was 0.11. And the median was 0.72.
XPAR:MLBBO's Equity-to-Asset is ranked better than 70.94% of 1132
companies
in the Retail - Cyclical industry
Industry Median: 0.44
vs XPAR:MLBBO: 0.59
Bebo Health (XPAR:MLBBO) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bebo Health Equity-to-Asset Related Terms
Bebo Health Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Bebo Health's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLBBO vs CASY, WSM, ULTA: Equity-to-Asset Comparison
For the Specialty Retail subindustry, Bebo Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bebo Health Equity-to-Asset vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bebo Health's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bebo Health's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bebo Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bebo Health (XPAR:MLBBO) has a Equity-to-Asset of 0.59 as of Dec. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bebo Health and its competitors. This is 18% below median its historical median of 0.72. Over the past decade, Bebo Health's Equity-to-Asset has ranged from 0.11 to 0.91. According to the industry distribution chart, Bebo Health ranks #329 out of 1132 companies in the Retail - Cyclical industry, placing it in the top 29.1%.
Is Bebo Health's Equity-to-Asset too high?
Bebo Health's current Equity-to-Asset of 0.59 is 18% below median its 10-year median of 0.72. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 0.91. The Retail - Cyclical industry median Equity-to-Asset is 0.44. Bebo Health's value of 0.59 is 34.1% above this industry median. Based on the distribution chart, Bebo Health ranks #329 out of 1132 companies in the Retail - Cyclical industry, which is above the industry midpoint. Overall, Bebo Health has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bebo Health's Equity-to-Asset compare to CASY and WSM?
According to the Retail - Cyclical industry distribution chart, Bebo Health ranks #329 out of 1132 companies for Equity-to-Asset. This puts Bebo Health in the upper half of its industry. The industry median Equity-to-Asset is 0.44. Bebo Health's value of 0.59 is 34.1% above this benchmark. Historically, Bebo Health's own Equity-to-Asset has ranged from 0.11 to 0.91 over the past decade. While the company's 10-year median is 0.72 vs. the industry median of 0.44, Bebo Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Retail - Cyclical company?
The median Equity-to-Asset among Retail - Cyclical companies is 0.44, based on 1,132 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bebo Health's current Equity-to-Asset of 0.59 is 34.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bebo Health and its competitors. For the Retail - Cyclical industry, the median Equity-to-Asset is 0.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bebo Health's current Equity-to-Asset is 0.59, which is 18% below median its own 10-year median of 0.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bebo Health stock overvalued right now?
Based on GuruFocus' analysis, Bebo Health (XPAR:MLBBO) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.03, compared to a current price of €0.18 — trading 513.3% above its estimated fair value. The current Equity-to-Asset is 0.59, which is 18% below median its 10-year median of 0.72 and 34.1% above the Retail - Cyclical industry median of 0.44. Bebo Health's overall GF Score™ is 47/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bebo Health (XPAR:MLBBO), the current Equity-to-Asset is 0.59 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bebo Health (XPAR:MLBBO) Overvalued in 2026?
Based on GuruFocus' analysis, Bebo Health stock appears to be overvalued.
The current stock price of €0.18 is trading 513.3% above its estimated GF Value™ of €0.03.
GuruFocus considers Bebo Health to be Significantly Overvalued.
Key valuation signals for XPAR:MLBBO:
Equity-to-Asset: 0.59 (18% below median its 10-year median of 0.72)
GF Value™: €0.03 vs. price of €0.18 (513.3% above fair value)
Industry Position: 34.1% above the Retail - Cyclical median (#329 of 1132)
No single metric tells the full story. See the XPAR:MLBBO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLBBO has been successfully added to your 
